Munafa Stock Market Course + Intraday & FNO calls 
Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Protagonist Therapeutics (PTGX)
Technical Analysis Report for NASDAQ stock PTGX Protagonist Therapeutics. Dated: 13 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock PTGX Protagonist Therapeutics then click here. or read Experts views on Protagonist Therapeutics or Forecast & share price targets of Protagonist Therapeutics
Protagonist Therapeutics Opened at 130.05 and Closed at: 129.89, which is -1.19% of previous session's close. It moved within a range of 125.32 and 131.36
The session was a Bearish session with an average volume of 541000, which is 17.75% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
Support for tomorrow is 124.59 and resistance for tomorrow is 130.63
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 126.35, 122.82 resistance for tomorrow's hourly charts is 132.39, 134.9
10 Day SMA for Protagonist Therapeutics (PTGX) is 131.25 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Protagonist Therapeutics (PTGX) is 123.52 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Protagonist Therapeutics (PTGX) is 109.9 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 103.85 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Protagonist Therapeutics is 92.69 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Protagonist Therapeutics is at 123.52 and 200 DMA is at 92.69, while 50 DMA and 100 DMA are at 109.9 and 103.85 respectively
Protagonist Therapeutics (PTGX) moving average of 20 SMA is at 123.52 and 20 EMA is at 124.54
| Date | Closing Price | 20 SMA | 20 EMA |
| 13 Mon Jul | 129.89 | 123.52 | 124.54 |
| 10 Fri Jul | 131.43 | 122.51 | 123.98 |
| 09 Thu Jul | 137.73 | 121.23 | 123.2 |
| 08 Wed Jul | 140.07 | 119.63 | 121.67 |
| 07 Tue Jul | 140.85 | 117.53 | 119.73 |
| 06 Mon Jul | 131.50 | 115.36 | 117.51 |
Protagonist Therapeutics (PTGX) moving average of 50 SMA is at 109.9 and 50 EMA is at 114.07
| Date | Closing Price | 50 SMA | 50 EMA |
| 13 Mon Jul | 129.89 | 109.9 | 114.07 |
| 10 Fri Jul | 131.43 | 109.28 | 113.42 |
| 09 Thu Jul | 137.73 | 108.63 | 112.68 |
| 08 Wed Jul | 140.07 | 107.9 | 111.66 |
| 07 Tue Jul | 140.85 | 107.06 | 110.5 |
| 06 Mon Jul | 131.50 | 106.25 | 109.26 |
Protagonist Therapeutics (PTGX) moving average of 100 SMA is at 103.85 and 100 EMA is at 105.36
| Date | Closing Price | 100 SMA | 100 EMA |
| 13 Mon Jul | 129.89 | 103.85 | 105.36 |
| 10 Fri Jul | 131.43 | 103.37 | 104.86 |
| 09 Thu Jul | 137.73 | 102.88 | 104.32 |
| 08 Wed Jul | 140.07 | 102.31 | 103.65 |
| 07 Tue Jul | 140.85 | 101.73 | 102.91 |
| 06 Mon Jul | 131.50 | 101.16 | 102.14 |
Protagonist Therapeutics (PTGX) moving average of 200 SMA is at 92.69 and 200 EMA is at 93.19
| Date | Closing Price | 200 SMA | 200 EMA |
| 13 Mon Jul | 129.89 | 92.69 | 93.19 |
| 10 Fri Jul | 131.43 | 92.37 | 92.82 |
| 09 Thu Jul | 137.73 | 92.04 | 92.43 |
| 08 Wed Jul | 140.07 | 91.67 | 91.97 |
| 07 Tue Jul | 140.85 | 91.28 | 91.48 |
| 06 Mon Jul | 131.50 | 90.89 | 90.98 |
Xencor Inc has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Xencor Inc, about 3.01% more returns!
Protagonist Therapeutics has performed better than Ptc Therapeutics in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Opko Health in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Omeros Corporation in short term. Holding Protagonist Therapeutics could be a better choice for now!
Myriad Genetics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Myriad Genetics, about 17.01% more returns!
Kura Oncology has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Kura Oncology, about 2.23% more returns!
Acadia Pharmaceuticals has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Acadia Pharmaceuticals, about 2.59% more returns!
Protagonist Therapeutics has performed better than Addus Homecare in short term. Holding Protagonist Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Audentes Therapeutics, about 54.73% more returns!
Celldex Therapeutics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Celldex Therapeutics, about 4.9% more returns!
Protagonist Therapeutics has performed better than Catalyst Pharmaceuticals in short term. Holding Protagonist Therapeutics could be a better choice for now!
Fennec Pharmaceuticals has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Fennec Pharmaceuticals, about 1.12% more returns!
Protagonist Therapeutics has performed better than Heron Therapeutics in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Idexx Laboratories in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Iridex Corporation in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics Technical analysis of indicators
Price action analysis of Protagonist Therapeutics (PTGX) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Protagonist Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Protagonist Therapeutics in short term and the buy signal is strong.
Protagonist Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Protagonist Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Protagonist Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 131.63 and Protagonist Therapeutics PTGX stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Protagonist Therapeutics PTGX stock. Volume based technical analysis of Protagonist Therapeutics PTGX stock is negative.
Protagonist Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock PTGX Protagonist Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And PTGX Experts View which covers a lot of information including buying and selling signals
PTGX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Protagonist Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
